[14–17] In metastatic colorectal cancer elevated levels of Interleukin 6, CRP and the NLR emerged as predictors of impaired disease outcome, whereas high levels of LMR seem to be associated with prolonged survival. This evidence concerns the gene CRP and metastatic colorectal cancer.